Cystic fibrosis, atopy, asthma and ABPA

Allergologia et Immunopathologia

Volumn 38, Issue 5, 2010, Pages 278-284

  Antunes, J ^a   Fernandes, A ^a   Miguel Borrego, L ^a,b   Leiria Pinto, P ^a   Cavaco, J ^a  

^a HOSPITAL DONA ESTEFÂNIA   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Allergic bronchopulmonary aspergillosis; Asthma; Atopy; Cystic fibrosis

Indexed keywords

RECOMBINANT ALLERGEN;

ASPERGILLOMA; ASPERGILLUS FUMIGATUS; ASTHMA; ATOPY; BRONCHITIS; BRONCHUS HYPERREACTIVITY; COMORBIDITY; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; FUNGAL COLONIZATION; HUMAN; LUNG ASPERGILLOSIS; LUNG FUNCTION; MOULD; MUCUS SECRETION; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SENSITIZATION; WHEEZING;

ALLERGENS; ANIMALS; ANTIGENS, FUNGAL; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASTHMA; BIOLOGICAL MARKERS; COMORBIDITY; CYSTIC FIBROSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION; LUNG; SPIROMETRY;

EID: 77957222834     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2010.06.002     Document Type: Review

References (92)

1. Mogayzel PJ, Flume PA. Update in cystic fibrosis 2009. Am J Respir Crit Care Med 2010, 181:539-544.
2. Warner JO, Taylor BW, Norman AP, Soothill JF. The association of cystic fibrosis with allergy. Arch Dis Child 1976, 51:507-511.
3. Warren CP, Tai E, Batten JC, Hutchcroft BJ, Pepys J Cystic fibrosis immunological reactions to A. fumigatus and common allergens. Clin Allergy 1975, 5:1-12.
4. Allan JD, Moss AD, Wallwork JC, McFarlane H Immediate hypersensitivity in patients with cystic fibrosis. Clin Allergy 1975, 5:255-261.
5. Warner JO. The variability of skin test hypersensitivity reactions in cystic fibrosis and asthma. Clin Allergy 1977, 7:385-389.
6. Lowe CU, May CD, Reed SC. Fibrosis of pancreas in infants and children: a statistical study of clinical and hereditary features. Am J Dis Child 1949, 78:349-374.
7. Kulczycki LL, Mueller H, Shwachman H. Respiratory allergy in patients with cystic fibrosis. JAMA 1961, 175:358-364.
8. Rachelefsky GS, Osher A, Dooley RE, Ank B, Stiehm ER. Coexistent respiratory allergy and cystic fibrosis. Am J Dis Child 1974, 128:355-359.
9. Torres-Lozano C, Núnez-Núnez ME, Pedroza-Meléndez A, Lezana JL, Huerta-López JG. Respiratory allergy in Mexican patients with cystic fibrosis. Allergol Immunopathol 1999, 27:294-297.
10. Barnes KC. Genetic studies of cystic fibrosis and atopic asthma: current approaches and future aspects. Pediatr Allergy Immunol 1996, 7:74-81.
11. Welsh MJ, Tsui LC, Boat FT, Beaudet AL. Cystic fibrosis. The metabolic and molecular bases of inherited disease 1995, vol. 3:3799-3876. McGraw-Hill, New York.
12. Zielenski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 1995, 29:777-807.
13. Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nature Genet 1996, 12:280-287.
14. Tizzano EF, Buchwald M. Cystic fibrosis: beyond the gene to therapy. J Pediatr 1992, 120:337-349.
15. Wilmott RW, Kassab JT, Kilian PL, Benjamin WR, Douglas D, Wood RE Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis 1990, 142:365-368.
16. Konstan MW, Hilliard KA, Norvell TM, Berger M.. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994, 150:448-454.
17. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995, 151:1075-1082.
18. Bedrossian CW, Greenberg SD, Singer DB, Hansen JJ, Rosenberg HS The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups. Hum Pathol 1976, 7:195-204.
19. Doring G, Dauner HM. Clearance of Pseudomonas aeruginosa in different rat lung infection models. Am Rev Respir Dis 1988, 138:1249-1253.
20. Dal Nogare AR, Toews GB, Pierce AK. Increased salivary elastase precedes gram-negative bacillary colonization in postoperative patients. Am Rev Respir Dis 1987, 135:671-675.
21. Brand PLP Bronchodilators in cystic fibrosis. J R Soc Med 2000, 93:37-39.
22. van Haren EH, Lammers JW, Festen J, van Herwaarden CL. Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis. Eur Respir J 1992, 5:1083-1088.
23. Balfour-Lynn IM, Elborn JS. "CF asthma": what is it and what do we do about it?. Thorax. 2002, 57:742-748.
24. Cooper PJ, Robertson CF, Hudson IL, Phelan PD Variability of pulmonary function tests in cystic fibrosis. Pediatr Pulmonol 1990, 8:16-22.
25. Sanders DB, Rosenfeld M, Mayer-Hamblett N, Stamey D, Redding GJ. Reproducibility of spirometry during cystic fibrosis pulmonary exacerbations. Pediatr Pulmonol 2008, 43:1142-1146.
26. Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 1998, 351:1911-1913.
27. Heijerman H, Westerman E, Conway S, Touw D, Döring G Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus. J Cyst Fibros 2009, 8:295-315. consensus working group.
28. Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009, 64:476-483. International Study of Asthma and Allergies in Childhood Phase Three Study Group.
29. Weinberger M. Airways reactivity in patients with CF. Clin Rev Allergy Immunol 2002, 23:77-85.
30. Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR deltaF508 mutation: a heterozygote advantage in cystic fibrosis. Nature Med 1995, 1:703-705.
31. van Asperen P, Mellis CM, South RT, Simpson SJ. Bronchial reactivity in cystic fibrosis with normal pulmonary function. Am J Dis Child 1981, 135:815-819.
32. Eggleston PA, Rosenstein BJ, Stackhouse CM, Alexander MF. Airway hyperreactivity in cystic fibrosis. Clinical correlates and possible effects on the course of the disease. Chest 1988, 94:360-365.
33. Mitchell I, Corey M, Woenne R, Krastins IRB, Levison H. Bronchial hyperreactivity in Cystic Fibrosis and Asthma. J Pediatr 1978, 93:744-748.
34. Sánchez I, Powell RE, Chernick V. Response to inhaled bronchodilators and nonspecific airway hyperreactivity in children with cystic fibrosis. Pediatr Pulmonol 1992, 14:52-57.
35. Valverde-Molina J, Sánchez-Solís M, Pastor-Vivero MD, García-Marcos L. Association between chronic colonization or infection with Pseudomonas aeruginosa and bronchial hyperreactivity in patients with cystic fibrosis. Arch Bronconeumol 2008, 44:180-184.
36. Sanchez I, Powell RE, Pasterkamp H. Wheezing and airflow obstruction during methacholine challenge in children with cystic fibrosis and in normal children. Am Rev Respir Dis 1993, 147:705-709.
37. Holzer FJ, Olinsky A, Phelan PD. Variability of airways hyper-reactivity and allergy in cystic fibrosis. Arch Dis Child 1981, 56:455-459.
38. Darga LL, Eason LA, Zach DM, Polgar G. Cold air provocation of airway hyperreactivity in patients with cystic fibrosis. Pediatr Pulmonol 1986, 2:82-88.
39. Balfour-Lynn IM. Cardiopulmonary function testing. Paediatrics. Physiotherapy for respiratory and cardiac problems. Children and adults 2002, 102-126. Harcourt Sciences, Edinburgh. 3rd ed. J.A. Pryor, S.A. Prasad (Eds.).
40. Yamashita Y, Okano M, Yoshino T, Hattori H, Yamamoto T, Watanabe T, et al. Carbohydrates expressed on Aspergillus fumigatus induce in vivo allergic Th2-type response. Clin Exp Allergy 2002, 32:776-782.
41. Allard JB, Poynter ME, Marr KA, Cohn L, Rincon M, Whittaker LA. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J Immunol 2006, 177:5186-5194.
42. Warner JO, Norman AP, Soothill JF. Cystic fibrosis heterozygosity in the pathogenesis of allergy. Lancet. 1976;1:1990-1991.
43. Munthe-Kaas MC, Lødrup Carlsen KC, Carlsen KH, Skinningsrud B, Håland G, Devulapalli CS, et al. CFTR gene mutations and asthma in the Norwegian Environment and Childhood Asthma study. Respir Med 2006, 100:2121-2128.
44. Douros K, Loukou I, Doudounakis S, Tzetis M, Priftis KN, Kanavakis E. Asthma and pulmonary function abnormalities in heterozygotes for cystic fibrosis transmembrane regulator gene mutations. Int J Clin Exp Med 2008, 1:345-349.
45. Dahl M, Nordestgaard BG, Lange P, Tybjaerg-Hansen A Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion. J Allergy Clin Immunol 2001, 107:818-823.
46. Leskowitz S, Salvaggio JE, Schwartz HE. An hypothesis for the development of atopic allergy in man. Clin Allergy 1972, 2:237-246.
47. Wallwork JC, McFarlane H The SIgA system and hypersensitivity in patients with cystic fibrosis. Clin Allergy 1976, 6:349-358.
48. Tobin MJ, Maguire O, Reen D, Tempany E, Fitzgerald MX Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax 1980, 35:807-813.
49. Warner JA, Little SA, Pollock I, Longbottom JL, Warner JO The influences of exposure to house dust mite, cat, pollen and fungal allergens in the home on primary sensitization in asthma. Pediatr Allergy Immunol 1990, 1:79-86.
50. Little SA, Longbottom JL, Warner JO. Optimised preparations of Aspergillus fumigatus extracts for allergy diagnosis. Clin Exp Allergy 1993, 23:835-842.
51. Warner JO, Kilburn SA. Cystic fibrosis and allergy. Pediatr Allergy Immunol 1996, 7:67-69.
52. Nikolaizik WH, Brueton MJ, Warner JO. Aspergillus allergy and allergic bronchopulmonary aspergillosis in cystic fibrosis. Pediatr Allergy Imrnunol 1991, 2:83-86.
53. Pitcher-Wilmott RW, Levinsky RJ, Gordon I, Turner MW, Matthew DJ. Pseudomonas infection, allergy and cystic fibrosis. Arch Dis Child 1982, 57:582-586.
54. Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis 1979, 120:863-873.
55. Schonheyder H, Jensen T, Hoiby N, Andersen P, Koch C. Frequency of Aspergillus fumigatus isolates and antibodies to Aspergillus antigens in cystic fibrosis. Acta Pathol Microbiol Immunol Scand 1985, 93:105-112.
56. Kurup VP, Apter AJ. Allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am 1998, 18:471-715.
57. Summerbell RC Taxonomy and ecology of Aspergillus species associated with colonizing infections of the respiratory tract. Immunol Allergy Clin North Am 1998, 18:549-573.
58. Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 2010, 36:1-53.
59. Knutsen AP, Mueller KR, Hutcheson PS, Slavin RG T- and B-cell dysregulation in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Clin Immunol Immunopathol 1990, 55:129-138.
60. Knutsen AP, Chauhan B, Slavin RG. Cell-mediated immunity in allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am 1998, 18:575-599.
61. Kurup VP, Banerjee B. Allergic aspergillosis: antigens and immunodiagnosis. Adv Med Mycol 1996, 2:133-154.
62. Parta M, Chang Y, Rulong S, Pinto-Da Silva P, Kwon-Chung KJ. HYP1, a hydrophobin gene from Aspergillus fumigatus, complements the rodletless phenotype in Aspergillus nidulans. Infect Immun 1994, 62:4389-4395.
63. Knutsen AP, Slavin RG. In vitro T cell responses in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Lab Clin Med 1989, 113:428-435.
64. Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med. 1986, 146:916-918.
65. Chotirmall SH, Branagan P, Gunaratnam C, McElvaney NG Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically challenging entity. Respir Care 2008, 53:1035-1041.
66. de Almeida MB, Bussamra MH, Rodrigues JC Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients. Paediatr Respir Rev 2006, 7:67-72.
67. Valletta EA, Braggion C, Mastella G Sensitization to Aspergillus and allergic bronchopulmonary aspergillosis in a cystic fibrosis population. Pediatr Asthma Allergy Immunol 1993, 7:43-49.
68. Wojnarowski C, Eichler I, Gartner C, Götz M, Renner S, Koller DY, et al. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med 1997, 155:1902-1907.
69. Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 1999, 115:364-370.
70. Hafen GM, Hartl D, Regamey N, Casaulta C, Latzin P. Allergic bronchopulmonary aspergillosis: the hunt for a diagnostic serological marker in cystic fibrosis patients. Expert Rev Mol Diagn 2009, 9:157-164.
71. Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: a European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2000, 16:464-471.
72. Brown JE, Greenberger PA, Yarnold PR. Soluble serum interleukin 2 receptors in patients with asthma and allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 1995, 74:484-488.
73. Latzin P, Hartl D, Regamey N, Frey U, Schoeni MH, Casaulta C. Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J 2008, 31:36-42.
74. Marchand E, Verellen-Dumoulin C, Mairesse M, Delaunois L, Brancaleone P, Rahier JF, et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001, 119:762-767.
75. Graves TS, Fink JN, Patterson R, Kurup VP, Scanlon GT. A familial occurrence of allergic bronchopulmonary aspergillosis. Ann Intern Med 1979, 91:378-382.
76. Chauhan B, Santiago L, Hutcheson PS, Schwartz HJ, Spitznagel E, Castro M, et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000, 106:723-729.
77. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, et al. Participants in the Cystic Fibrosis Foundation Consensus Conference. Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis - State of the Art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003, 37:225-264.
78. Knutsen AP, Kariuki B, Consolino JD, Warrier MR. IL-4 alpha chain receptor (IL-4Ralpha) polymorphisms in allergic bronchopulmonary sspergillosis. Clin Mol Allergy 2006, 17. 4-3.
79. Kraemer R, Deloséa N, Ballinari P, Gallati S, Crameri R. Effect of Allergic Bronchopulmonary Aspergillosis on Lung Function in Children with Cystic Fibrosis. Am J Respir Crit Care Med 2006, 174:1211-1220.
80. Miller PW, Hamosh A, Macek M, Greenberger PA, MacLean J, Walden SM, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996, 59:45-51.
81. Burns JL, Van Dalfsen JM, Shawar RM, Otto KL, Garber RL, Quan JM, et al. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis 1999, 179:1190-1196.
82. Skov M, Pressler T, Jensen HE, Hoiby N, Koch C. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 1999, 54:44-50.
83. Nikolaizik WH, Moser M, Crameri R, Little S, Warner JO, Blaser K, et al. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. Am J Respir Crit Care Med 1995, 152:634-639.
84. Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 1988, 81:646-650.
85. Hutcheson PS, Knutsen AP, Regent AJ, Slavin RG A twelve year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis. Chest 1996, 110:363-366.
86. Crameri R, Hemmann S, Ismail C, Menz G, Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol 1998, 10:1211-1216.
87. Schwartz HJ, Citron KM, Chester EH, Kaimal J, Barlow PB, Baum GL, et al. A comparison of the prevalence of sensitization to Aspergillus antigens among asthmatics in Cleveland and London. J Allergy Clin Immunol 1978, 62:9-14.
88. Hemmann S, Nikolaizik WH, Schoni MH, Blaser K, Crameri R. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Eur J Immunol 1998, 28:1155-1160.
89. Geller DE, Kaplowitz H, Light MJ, Colin AA. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Chest 1999, 116:639-646.
90. Slavin RG, Hutcheson PS, Chauhan B, Bellone CJ. An overview of allergic bronchopulmonary aspergillosis with some new insights. Allergy Asthma Proc 2004, 25:395-399.
91. Hemmann S, Menz G, Ismail C, Blaser K, Crameri R. Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization. J Allergy Clin Immunol 1999, 104:601-607.
92. Hogaboam CM, Carpenter KJ, Schuh JM, Buckland KF Aspergillus and asthma: any link?. Med Mycol 2005, 43:197-202.